CAS 5470-11-1|Hydroxyamine hydrochloride

Introduction:Basic information about CAS 5470-11-1|Hydroxyamine hydrochloride, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
Common NameHydroxyamine hydrochloride
CAS Number5470-11-1Molecular Weight69.491
Density1.67 g/mL at 25 °C(lit.)Boiling Point56.5ºC at 760mmHg
Molecular FormulaClH4NOMelting Point155-157 °C (dec.)(lit.)
MSDSChineseUSAFlash Point/
Symbol
GHS05, GHS07, GHS08, GHS09
Signal WordWarning

Names

NameHydroxylamine hydrochloride
SynonymMore Synonyms

Hydroxyamine hydrochloride BiologicalActivity

DescriptionHydroxyamine hydrochloride is a selective monoamine oxidase (MAO) inhibitor used for inhibiting of platelet aggregation. Hydroxyamine hydrochloride is an intermediate of organic synthesis[1].
Related CatalogResearch Areas >>Cardiovascular DiseaseSignaling Pathways >>Neuronal Signaling >>Monoamine Oxidase
In VitroHydroxyamine hydrochloride (1 mM) inhibits the activity of MAO for 99.8%[1].
References

[1]. Roh JH, et al. Purification, characterization, and crystallization of monoamine oxidase from Escherichia coli K-12. Biosci Biotechnol Biochem. 1994 Sep;58(9):1652-6.

Chemical & Physical Properties

Density1.67 g/mL at 25 °C(lit.)
Boiling Point56.5ºC at 760mmHg
Melting Point155-157 °C (dec.)(lit.)
Molecular FormulaClH4NO
Molecular Weight69.491
Exact Mass68.998138
PSA46.25000
LogP0.83660
InChIKeyWTDHULULXKLSOZ-UHFFFAOYSA-N
SMILESCl.NO
Storage conditionStore at RT.
StabilitySubstances to be avoided include strong oxidizing agents. Heating above 115 C may cause explosion; do not store above 65C. Moisture and air sensitive.
Water Solubility560 g/L (20 ºC)

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
NC3675000
CHEMICAL NAME :
Hydroxylamine, hydrochloride
CAS REGISTRY NUMBER :
5470-11-1
LAST UPDATED :
199710
DATA ITEMS CITED :
46
MOLECULAR FORMULA :
Cl-H.H3-N-O
MOLECULAR WEIGHT :
69.50
WISWESSER LINE NOTATION :
ZQ &GH

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
141 mg/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
408 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
10 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
125 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
70 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
49500 mg/kg/25W-I
TOXIC EFFECTS :
Endocrine - changes in spleen weight Endocrine - changes in thyroid weight
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
2478 mg/kg/6D-C
TOXIC EFFECTS :
Behavioral - food intake (animal) Blood - changes in leukocyte (WBC) count Nutritional and Gross Metabolic - weight loss or decreased weight gain
TYPE OF TEST :
Specific locus test
TYPE OF TEST :
Cytogenetic analysis

MUTATION DATA

TYPE OF TEST :
Sister chromatid exchange
TEST SYSTEM :
Mammal - species unspecified Lymphocyte
DOSE/DURATION :
25 mg/L
REFERENCE :
IJEBA6 Indian Journal of Experimental Biology. (Publications & Information Directorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963- Volume(issue)/page/year: 20,726,1982 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - 38950 No. of Facilities: 1202 (estimated) No. of Industries: 18 No. of Occupations: 11 No. of Employees: 6578 (estimated) NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - 38950 No. of Facilities: 1258 (estimated) No. of Industries: 20 No. of Occupations: 26 No. of Employees: 15258 (estimated) No. of Female Employees: 4469 (estimated)

Safety Information

Symbol
GHS05, GHS07, GHS08, GHS09
Signal WordWarning
Hazard StatementsH290-H302 + H312-H315-H317-H319-H351-H373-H410
Precautionary StatementsP273-P280-P305 + P351 + P338-P501
Personal Protective EquipmentEyeshields;Faceshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges
Hazard CodesXn:Harmful
Risk PhrasesR22;R36/38;R43;R48/22;R50
Safety PhrasesS22-S24-S37-S61
RIDADRUN 2923 8/PG 2
WGK Germany3
RTECSNC3675000
Packaging GroupIII
Hazard Class8
HS Code2935009090

Customs

HS Code2935009090
Summary2935009090 other sulphonamides VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:35.0%

Articles70

More Articles
The identification of a novel SIRT6 modulator from Trigonella foenum-graecum using ligand fishing with protein coated magnetic beads.

J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 968 , 105-11, (2014)

SIRT6 is a histone deacetylase that has been proposed as a potential therapeutic target for metabolic disorders and the prevention of age-associated diseases. Thus the identification of compounds that...

Superparamagnetic iron oxide nanoparticles exacerbate the risks of reactive oxygen species-mediated external stresses.

Arch. Toxicol. 89(3) , 357-69, (2015)

Superparamagnetic iron oxide nanoparticles (IONPs) have been widely applied in numerous biomedical fields. The evaluation of the toxicity of IONPs to the environment and human beings is indispensable ...

Novel oral phosphate binder with nanocrystalline maghemite-phosphate binding capacity and pH effect.

Int. J. Pharm. 482(1-2) , 21-6, (2015)

Hyperphosphatemia is one of the main risk factors contributing to morbidity and mortality in patients with end stage renal disease. The demand for a new phosphate binder is continuously increasing sin...

Synonyms

EINECS 226-798-2
MFCD00051089
Hydroxylammonium chloride
Ammonium, hydroxy-, chloride (1:1)
hydroxylamine,hydrochloride
CAS 109-76-2|1,3-Diaminopropane
CAS 5263-87-6|6-Methoxyquinoline
Recommended......
TOP